MIC Capital Management UK LLP
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), MIC Capital Management UK LLP reported 12 stock positions worth $460.0 million. Its top holding was Endeavor Group Hold Class A (EDR) at 50.2% of the portfolio, followed by Recursion Pharmaceuticals-A (RXRX, 13.8%) and Neumora Therapeutics (NMRA, 9.5%). Compared with Q1 2024, it sold out of 4. The biggest sale was an exit from Grab Class A (GRAB).
- Most Recent 13F
- Q2 2026
- Location
- LONDON, X0
- CIK
- 0001889830
- Portfolio Value
- $460.0M (Q2 2024)
- SEC Filing
- 0001085146-24-003969 ↗ filed Aug 14, 2024
Holdings Value
Holdings 12 stocks · $460.0M
| EDR Endeavor Group Hold Class A | 50.16% | 8,536,456 | $230.7M | No change |
| RXRX Recursion Pharmaceuticals-A | 13.78% | 8,451,758 | $63.4M | No change |
| NMRA Neumora Therapeutics Inc. | 9.53% | 4,460,700 | $43.8M | No change |
| CPNG Coupang Inc. | 6.43% | 1,412,946 | $29.6M | No change |
| QSR Restaurant Brands Intern | 5.91% | 386,203 | $27.2M | No change |
| RVMD Revolution Medicines Inc. | 4.29% | 508,569 | $19.7M | No change |
| META Meta Platforms Inc. Class A | 3.65% | 33,300 | $16.8M | No change |
| BABA Alibaba Group Holding-SP ADR | 2.35% | 150,000 | $10.8M | No change |
| EXAI Exscientia Ltd. | 1.71% | 1,542,600 | $7.9M | No change |
| YMM Full Truck Alliance -SPN ADR | 1.10% | 630,697 | $5.1M | No change |
| LYEL Lyell Immunopharma Inc. | 0.55% | 1,740,569 | $2.5M | No change |
| ACHR Archer Aviation Inc. Class A | 0.54% | 700,000 | $2.5M | No change |
Portfolio Sells Q1 2024 → Q2 2024
Portfolio Buys Q1 2024 → Q2 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 16 | $394.3M | HAYW, RVMD, RXRX, QSR, CPNG |
| Q1 2026 | 14 | $352.5M | HAYW, RVMD, KLAR, RXRX, QSR |
| Q4 2025 | 13 | $441.3M | HAYW, KLAR, RVMD, RXRX, CPNG |
| Q3 2025 | 13 | $500.3M | HAYW, KLAR, RXRX, CPNG, GRAB |
| Q2 2025 | 13 | $509.3M | HAYW, MTSR, RXRX, CPNG, QSR |
| Q1 2025 | 14 | $490.8M | HAYW, MTSR, RXRX, CPNG, QSR |
| Q4 2024 | 14 | $706.3M | EDR, HAYW, RXRX, NMRA, CPNG |
| Q3 2024 | 15 | $720.1M | EDR, HAYW, NMRA, RXRX, CPNG |
| Q2 2024 | 12 | $460.0M | EDR, RXRX, NMRA, CPNG, QSR |
| Q1 2024 | 16 | $526.5M | EDR, RXRX, NMRA, QSR, CPNG |